Eksperimental'naia i klinicheskaia farmakologiia 2013-01-01

[Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone].

V S Rogovskiĭ, M A Rozenfel'd, S D Razumovskiĭ, A I Matiushin, N L Shimanovskiĭ, B V Leonova, M L Konstantinova

文献索引：Eksp. Klin. Farmakol. 76(3) , 23-6, (2013)

全文：HTML全文

摘要

The ability of dihydroquercetin to inhibit the oxidation of fibrinogen has been evaluated. It is established that dihydroquercetin inhibits oxidation of fibrinogen by ozone, thus preventing oxidative modification of fibrinogen and preserving its functional activity.